Delivery Order SPE2DB20D1109-SPE2DB21FQ11Y
- Not listed
- This federal contract award is for the delivery of Erythromycin 0.5% eye ointment to the Defense Logistics Agency (DLA). The $1,777.58 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of December 13, 2022 and was awarded on December 12, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Erythromycin 0.5% eye ointment to the Defense Logistics Agency (DLA), a key procurement agency for the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,246.50, is a Firm Fixed Price Delivery Order with a completion date of November 30, 2021. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams, to the U.S. Department of Defense's Medical Supply Chain, also known as the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,695.55, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 26, 2024. This award is not designated as a set-aside...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,536.33 Firm Fixed Price delivery order is for the supply of Erythromycin 0.5% eye ointment. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. The IDC, which runs through November 2026, serves...
- This federal contract award, valued at $3,088.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Erythromycin 0.5% eye ointment, a pharmaceutical product, with a completion date of December 28, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams, to the Defense Logistics Agency (DLA). The contract, valued at $1,266.59, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,266.59 and an ultimate completion date of December 11, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract has no set-aside designation, indicating full and open...
- This federal contract award is for the delivery of Erythromycin 0.5% eye ointment, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,788.58 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,119.93 firm fixed price delivery order is for the supply of Erythromycin 0.5% Eye Ointment 3.5GM to support military treatment programs and facilities. The award has a performance period through March 18, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams, with a ceiling value of $1,507.52 and a completion date of May 13, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award, which...
- This federal contract award is for the delivery of Erythromycin 0.5% eye ointment (3.5 grams) to the Defense Logistics Agency (DLA). The $8,320.47 firm fixed-price delivery order was awarded on August 18, 2022 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with an ultimate completion date of August 19, 2022. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through December 31, 2025, which serves as the primary...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB21FQ11YDelivery Order
This federal contract award is for the delivery of Erythromycin 0.5% eye ointment to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,004.99 firm fixed-price contract is a delivery order with a completion date of September 27, 2021. There is no set-aside designation, indicating the contract was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier of pharmaceutical products and medical supplies to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, enabling efficient government procurement of essential medical commodities, including specialty medications, generic drugs, and medical devices, to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/24/21 |